Literature DB >> 19751623

Implementation of a bundle of actions to improve adherence to the Surviving Sepsis Campaign guidelines at the ED.

José M De Miguel-Yanes1, Javier Muñoz-González, Juan A Andueza-Lillo, Berta Moyano-Villaseca, Víctor J González-Ramallo, Ana Bustamante-Fermosel.   

Abstract

PURPOSES: We had previously demonstrated surviving sepsis campaign guidelines had not had enough impact at our Emergency Department. BASIC PROCEDURES: Actions directed to increase the qualification of our staff and residents, to facilitate guidelines divulgation and to improve spatial conditions by creating a High Dependency Unit were implemented as a bundle. The impact of these actions on the achievement of early objectives of the campaign and on mortality was analyzed. MAIN
FINDINGS: Following campaign guidelines was more frequent after the implementation of these actions, as shown by less restrictive fluids administration for more severe cases (P = .001), earlier administration of antibiotics (P = .001) and lactate determination rate (46% vs. 12%). In-hospital mortality difference did not reach statistical difference. Physicians were able to identify high-risk patients on clinical grounds. PRINCIPAL
CONCLUSIONS: The bundle of actions has had a moderate beneficial effect on our Emergency Department. High Dependency Units are useful for managing patients not fulfilling criteria for Intensive Care Unit admission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751623     DOI: 10.1016/j.ajem.2008.05.010

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  8 in total

1.  An automated dispensing system for improving medication timing in the emergency department.

Authors:  Michael J Ward; Jeremy S Boyd; Nicole J Harger; John M Deledda; Carol L Smith; Susan M Walker; Jeffrey D Hice; Kimberly W Hart; Christopher J Lindsell; Stewart W Wright
Journal:  World J Emerg Med       Date:  2012-06-12

Review 2.  Early management of sepsis with emphasis on early goal directed therapy: AME evidence series 002.

Authors:  Zhongheng Zhang; Yucai Hong; Nathan J Smischney; Han-Pin Kuo; Panagiotis Tsirigotis; Jordi Rello; Win Sen Kuan; Christian Jung; Chiara Robba; Fabio Silvio Taccone; Marc Leone; Herbert Spapen; David Grimaldi; Sven Van Poucke; Steven Q Simpson; Patrick M Honore; Stefan Hofer; Pietro Caironi
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

3.  Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting.

Authors:  Sandra Christina Pereira Lima Shiramizo; Alexandre R Marra; Marcelino S Durão; Ângela T Paes; Michael B Edmond; Oscar Fernando Pavão dos Santos
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

Review 4.  Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies.

Authors:  Elisa Damiani; Abele Donati; Giulia Serafini; Laura Rinaldi; Erica Adrario; Paolo Pelaia; Stefano Busani; Massimo Girardis
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

5.  Protocol-Based Resuscitation for Septic Shock: A Meta-Analysis of Randomized Trials and Observational Studies.

Authors:  Woo Kyung Lee; Ha Yeon Kim; Jinae Lee; Shin Ok Koh; Jeong Min Kim; Sungwon Na
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

6.  Outcome predictors of uncomplicated sepsis.

Authors:  Ewoud Ter Avest; Maarten de Jong; Ineke Brűmmer; Götz Jk Wietasch; Jan C Ter Maaten
Journal:  Int J Emerg Med       Date:  2013-04-08

7.  Continuous Insulin Infusion: When, Where, and How?

Authors:  Janet L Kelly
Journal:  Diabetes Spectr       Date:  2014-08

Review 8.  Current aspects in sepsis approach. Turning things around.

Authors:  F J Candel; M Borges Sá; S Belda; G Bou; J L Del Pozo; O Estrada; R Ferrer; J González Del Castillo; A Julián-Jiménez; I Martín-Loeches; E Maseda; M Matesanz; P Ramírez; J T Ramos; J Rello; B Suberviola; A Suárez de la Rica; P Vidal
Journal:  Rev Esp Quimioter       Date:  2018-06-25       Impact factor: 1.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.